Skip to content
Home/Companies/Biotech/TES Pharma
TP

TES Pharma

Biotech·Italy·Active·2yr hold

TES Pharma is a biotech company, headquartered in Italy.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns TES Pharma?

TES Pharma is currently owned by XGen Venture SGR through XGEN Venture Life Sciences Fund (2022 vintage), since 2024. Across its history, TES Pharma has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-23

XGen Venture SGR
Most recent investor
XGen Venture SGR
XGEN Venture Life Sciences Fund · 2022 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQItaly
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by XGen Venture SGR and Indaco Venture Partners SGR since 2024.
Co-invest · 2 holders · 2024 · present
XGen Venture SGR
XGen Venture SGRActive
2024 · present · XGEN Venture Life Sciences Fund · 2022 · Life Sciences VC
MOIC
–
Indaco Venture Partners SGR
Indaco Venture Partners SGRActive
2025 · present · Indaco BIO · 2022 · Life Sciences VC
MOIC
–

More from XGEN Venture Life Sciences Fund

Other portfolio companies in the same fund.

AAVantgarde
Active
BiotechItaly· 2025
EpilepsyGTx
Active
BiotechUnited Kingdom· 2025
Gesynta Pharma
Active
BiotechSweden· 2025
Nanophoria
Active
BiotechItaly· 2025
Genespire
Active
BiotechItaly· 2024
iOnctura
Active
BiotechSwitzerland· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Active
Amadeus Capital PartnersUK
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings